Welcome
The Charity Medicines Access Coalition works to find long-term solutions to the challenges that can delay or prevent patient access to medicines.
The coalition is chaired by Myeloma UK and brings together 30 health charities representing millions of people across a range of disease areas.
Working together, we strengthen charity voices in debates around new medicines, focusing our actions and recommendations on:
- Identifying and supporting ways to improve the adoption of new medicines into the NHS.
- Acting as an honest broker and critical friend to key decision-makers to remove current and potential barriers that are preventing people accessing newer or better treatment options.
- Ensuring people with lived experience are at the heart of regulatory and approval processes when decisions are made about the value and affordability of new medicines.
To help support discussions around new medicines, the coalition has established relationships with decision-makers across the healthcare system. This includes NHS England, the National Institute for Health and Care Excellence (NICE), the Medicines and Healthcare products Regulatory Agency (MHRA), the Department of Health and Social Care (DHSC) and the Association of the British Pharmaceutical Industry (ABPI).
